Autres langues PT Kalbe Farma Tbk.

Actions

KLBF

ID1000125107

Cours en clôture INDONESIA S.E. Autres places de cotation 00:00:00 03/05/2024			Varia. 5j.	Varia. 1 janv.
1 490 ^IDR	0,00%		+6,05%	-7,45%

30/04	PT Kalbe Farma Tbk. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
01/04	PT Kalbe Farma Tbk. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

PT Kalbe Farma Tbk : Company Update - Q1 2024 Unaudited Results (02-May-2024)	02/05
PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
PT Kalbe Farma Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2023	31/10/23
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)	23/10/23
Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius novel anti-PD-1 mAb HANSIZHUANG in MENA	13/09/23
PT Kalbe Farma Tbk : KIMIA FARMA & KALBE FARMA COLLABORATED TO IMPROVE HEALTH SERVICES FOR THE SOCIETY	01/09/23
PT Kalbe Farma Tbk. Reports Earnings Results for the Half Year Ended June 30, 2023	07/08/23
PT Kalbe Farma Tbk : KALBE INTRODUCES MESOTHERAPY PRODUCTS IN AESTHETIC TREATMENT	17/07/23
PT Kalbe Farma Tbk : KALBE INTRODUCES AUTOIMMUNE DISEASES FURTHER	08/07/23
PT Kalbe Farma Tbk : Kalbe Announced Dividend of 52% from Net Profit	04/05/23
PT Kalbe Farma Tbk : 2022, Recover Together for Healthier Nation	02/05/23
PT Kalbe Farma Tbk : Kalbe Maintained Double Digit Top Line Growth in the First Quarter of 2023	28/04/23
PT Kalbe Farma Tbk : Company Update - Q1 2023 Unaudited Results (28-April-2023)	28/04/23
PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2022	28/03/23
PT Kalbe Farma Tbk : THE INAUGURATION OF THE KALBE UBAYA HANBANG-BIO LABORATORY PILOT PLANT, SUPPORTING THE INDEPENDENCE OF NATIONAL INGREDIENTS	02/03/23
Progen Co. Ltd. announced that it has received IDR 155.72 billion in funding from PT Kalbe Farma Tbk.	02/01/23
PT Kalbe Farma Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2022	31/10/22
PT Kalbe Farma Tbk. completed the acquisition of a 80% stake in PT Aventis Pharma from Hoechst GmbH and Sanofi-Aventis Participations S.A.S.	26/10/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues PT Kalbe Farma Tbk.

Actions

KLBF

ID1000125107

Autres langues

Filtres